Emergent BioSolutions (EBS) Tops Q2 EPS by 49c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.54 -0.4%
Financial Fact:
Research and development: 27.19M
Today's EPS Names:
LTBR, ELVN, GLXY, More
Financial Fact:
Research and development: 27.19M
Today's EPS Names:
LTBR, ELVN, GLXY, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of $0.60, $0.49 better than the analyst estimate of $0.11. Revenue for the quarter came in at $234.3 million versus the consensus estimate of $186 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Park-Ohio Holdings (PKOH) Tops Q2 EPS by 11c; raises guidance
- Chime Financial, Inc. (CHYM) Tops Q2 EPS by 17c ; Offers Guidance
- Hennessy Advisors, Inc. (HNNA) Reports Q3 EPS of $0.25
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
